Medication info
Telmisartan Plus Tablet 40/12.5 Milligrams

Telmisartan Plus Tablet 40/12.5 Milligrams

Prescription medicationTabletOral
Ingredient · strength
Telmisartan›40mg / 1 tabletHydrochlorothiazide›12.5mg / 1 tablet
Manufacturer / importer
Hanwha Pharmaceutical Co., Ltd.
Appearance
White or almost white, double-sided, convex circular tablets
Packaging
10 tablets/Blister X 3
Approval status
Active

MFDS item code 201603228 · Approved 2016.06.07 · Insurance code 651602040

Summary

Main use
Treatment of essential hypertension not controlled with telmisartan alone
Who takes it
Adults · Children
Adult dose
Adults For patients whose blood pressure is not adequately controlled with telmisartan monotherapy, take this medicine once daily with a beverage, regardless of meals. Before switching to this medicine, in which the doses of the individual components are fixed, it is recommended that the dose of each component be adjusted individually. When clinically appropriate, switching directly from monotherapy to this medicine may also be considered. - The telmisartan/hydrochlorothiazide combination 40/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 40mg. - The telmisartan/hydrochlorothiazide combination 80/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg. - The telmisartan/hydrochlorothiazide combination 80/25mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg and hydrochlorothiazide 12.5mg given concomitantly as separate tablets or as a combination product. Sodium or volume depletion should be corrected before starting this medicine. Patients with renal impairment No dose adjustment is necessary in patients with mild to moderate renal impairment. This medicine should not be administered to patients with severe renal impairment (creatinine clearance<30mL/min). Periodic monitoring of renal function is recommended. Patients with hepatic impairment Administer this medicine with caution to patients with mild to moderate hepatic impairment. The daily dose should not exceed 40/12.5mg. This medicine should not be administered to patients with severe hepatic impairment (see Precautions for Use, section 2). Thiazide diuretics should be administered with caution to patients with impaired liver function. Elderly patients No dose adjustment is necessary.
Child dose
The safety and efficacy of this medicine have not been established in children under 18 years of age.

Ingredients

Manufacturer
Hanwha Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with telmisartan alone

  • Essential hypertension
View approved original text

This medicine is used for the treatment of essential hypertension. It helps effectively control blood pressure by adding therapy for patients whose blood pressure is not sufficiently controlled by telmisartan alone. As a result, it improves blood pressure management and helps reduce the risk of cardiovascular complications.

How to take

Adult dose

Adults For patients whose blood pressure is not adequately controlled with telmisartan monotherapy, take this medicine once daily with a beverage, regardless of meals. Before switching to this medicine, in which the doses of the individual components are fixed, it is recommended that the dose of each component be adjusted individually. When clinically appropriate, switching directly from monotherapy to this medicine may also be considered. - The telmisartan/hydrochlorothiazide combination 40/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 40mg. - The telmisartan/hydrochlorothiazide combination 80/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg. - The telmisartan/hydrochlorothiazide combination 80/25mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg and hydrochlorothiazide 12.5mg given concomitantly as separate tablets or as a combination product. Sodium or volume depletion should be corrected before starting this medicine. Patients with renal impairment No dose adjustment is necessary in patients with mild to moderate renal impairment. This medicine should not be administered to patients with severe renal impairment (creatinine clearance<30mL/min). Periodic monitoring of renal function is recommended. Patients with hepatic impairment Administer this medicine with caution to patients with mild to moderate hepatic impairment. The daily dose should not exceed 40/12.5mg. This medicine should not be administered to patients with severe hepatic impairment (see Precautions for Use, section 2). Thiazide diuretics should be administered with caution to patients with impaired liver function. Elderly patients No dose adjustment is necessary.

Child dose

The safety and efficacy of this medicine have not been established in children under 18 years of age.

Precautions

This medicine can cause serious harm or risk of death to the fetus during pregnancy, especially in the second and third trimesters, so it should be discontinued immediately if pregnancy is confirmed. Patients with allergies to the ingredients of this medicine, certain liver or kidney diseases, pregnant women, and nursing mothers should not take this medicine. Elderly patients, those with high potassium levels, weak liver function, or heart valve disease should use this medicine with caution. The hydrochlorothiazide component can cause photosensitivity reactions that may increase the risk of skin cancer, so it is important to avoid sun exposure and inform a doctor immediately if skin abnormalities occur. Although this medication lowers blood pressure, it may cause hypotension, dizziness, and electrolyte imbalances (especially changes in potassium and sodium levels); if symptoms occur, consult a healthcare professional immediately. Patients with impaired kidney function should undergo regular blood tests to monitor kidney function and electrolyte status. Interactions may occur when used in conjunction with other antihypertensive agents, certain diuretics, lithium, potassium supplements, etc., so inform the healthcare professional about any other medications being taken. Dizziness or drowsiness may occur when driving or operating machinery, so caution should be exercised if symptoms are present. Overdosing on this medication may lead to hypotension, electrolyte imbalances, dehydration, etc., and immediate emergency treatment is required in such cases. Safety and efficacy in pediatric patients have not been established, and it is not recommended.

Side effects

  • Bronchitis
  • pharyngitis
  • sinusitis
  • hypokalemia
  • hyperuricemia
  • hyponatremia
  • anxiety
  • depression
  • insomnia
  • sleep disorders
Show 116 more
  • dizziness
  • syncope
  • paresthesia
  • visual impairment
  • blurred vision
  • vertigo
  • tachycardia
  • arrhythmia
  • hypotension
  • orthostatic hypotension
  • dyspnea
  • respiratory distress
  • pulmonary inflammation
  • pulmonary edema
  • diarrhea
  • dry mouth
  • abdominal distension
  • abdominal pain
  • constipation
  • dyspepsia
  • vomiting
  • gastritis
  • abnormal liver function
  • liver disease
  • angioedema
  • erythema
  • pruritus
  • rash
  • hyperhidrosis
  • urticaria
  • back pain
  • muscle cramp
  • myalgia
  • arthralgia
  • limb pain
  • systemic lupus erythematosus
  • erectile dysfunction
  • chest pain
  • influenza-like illness
  • pain
  • increased blood uric acid
  • increased blood creatinine
  • increased blood creatine phosphokinase
  • increased liver enzymes
  • upper respiratory infection
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
  • eosinophilia
  • thrombocytopenia
  • anaphylactic reaction
  • hyperkalemia
  • hypoglycemia
  • drowsiness
  • bradycardia
  • cough
  • interstitial lung disease
  • dry mouth
  • abdominal discomfort
  • taste disturbance
  • eczema
  • drug rash
  • toxic skin rash
  • pain crisis
  • renal dysfunction
  • weakness
  • increased blood creatine phosphokinase
  • decreased hemoglobin
  • thrombocytopenic purpura
  • hemolytic anemia
  • bone marrow failure
  • leukopenia
  • agranulocytosis
  • hypersensitivity
  • sialadenitis
  • non-melanoma skin cancer
  • thrombocytopenia
  • hypomagnesemia
  • hyperglycemia
  • hypercalcemia
  • hypochloremic alkalosis
  • necrotizing vasculitis
  • acute respiratory distress syndrome
  • nausea
  • pancreatitis
  • jaundice
  • cholestasis
  • photosensitivity reaction
  • toxic epidermal necrolysis
  • lupus-like syndrome
  • systemic erythematosus lupus
  • acute renal failure
  • diabetes
  • weakness
  • fever
  • nausea
  • gastrointestinal bleeding
  • esophagitis
  • headache
  • tremors
  • facial flush
  • malaise
  • fatigue
  • weight loss
  • proteinuria
  • pruritus
  • myalgia
  • floating sensation
  • lip and hand tremors
  • hypersensitivity
  • gum disease
  • lip dryness
  • decreased vision
  • hypoglycemia
  • intestinal vascular edema

Not everyone experiences these, and they can vary from person to person.

Storage

Store this medicine in a tightly sealed container to prevent exposure to air or moisture. It is also important to store it at room temperature between 1 to 30 degrees Celsius to maintain its effectiveness.

Appearance and packaging

Appearance

White or almost white, double-sided, convex circular tablets

Package unit

10 tablets/Blister X 3

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.